Price of domestically produced Nilotinib in 2023

Nilotinib (Nilotinib) is a drug used to treat chronic myelogenous leukemia (CML), a type of blood cancer. Nilotinib is suitable for newly diagnosed patients or patients who cannot take other cancer drugs (including imatinib) because of side effects or ineffectiveness.

Nilotinib contains the active ingredientnilotinib works only in patients whose cancer cells carry a special chromosome called the Philadelphia chromosome. Nilotinib is used in adults and children during the chronic stages of cancer, when the disease progresses slowly and patients have few or no symptoms. It can also be used in adults who are in accelerated phase (when cancer cells are dividing rapidly and patients may have more symptoms). Chronic myeloid leukemia (CML) is rare, and nilotinib was designated an "orphan drug" (a drug for rare diseases) on May 22, 2006.

The original drug Nilotinib is marketed in China under the name Nilotinib and is covered by medical insurance, but it is only reimbursed for patients who meet the indications. SpecificationsThe price of 150mg*120 capsules per box may be around RMB 9,000. At present, domestic drugs produced by Qilu Pharmaceutical and Terry Pharmaceuticals have been approved for marketing in China, but the specific price has not yet been determined. The Indian version of the original drug Nilotinib sold overseas may cost around 1,000 yuan per box of 150mg*28 capsules (the price may fluctuate due to exchange rates). The ingredients of the original drug sold domestically and abroad are basically the same. There is currently no generic version of Nilotinib on the market. For more drug information and specific prices, please consult a medical consultant.